Search results - 2 results
Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe.
828 pwCF and SARS-CoV-2 infection. Incidence was 17.2 per 1000 pwCF (95% CI: 16.0-18.4). Median age was 24 years, 48.4% were male and 9.4% had lung transplants. SARS-CoV-2 incidence was higher in ...
Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study.
1555 people with CF, 1452 were included in the analysis. One third were aged <18 years, and 9.4% were solid-organ transplant recipients. 74.5% were symptomatic and 22% were admitted to hospital. In ...